XML 26 R13.htm IDEA: XBRL DOCUMENT v3.22.0.1
Note 6 - Identified Intangible Assets
12 Months Ended
Dec. 31, 2021
Notes to Financial Statements  
Intangible Assets Disclosure [Text Block]

6. IDENTIFIED INTANGIBLE ASSETS

 

A schedule of identified intangible assets is as follows:

  

Gross

  

Accumulated

  

Carrying

 

($ in thousands)

 

Amount

  

Amortization

  

Amount

 

December 31, 2021

            

Trademarks

            

Wholesale (1)

 $72,579   -  $72,579 

Retail (2)

  9,220   -   9,220 

Patents

  895  $804   91 

Customer relationships (3)

  46,900   2,475   44,425 

Total Intangibles

 $129,594  $3,279  $126,315 

 

  

Gross

  

Accumulated

  

Carrying

 

($ in thousands)

 Amount  Amortization  Amount 

December 31, 2020

            

Trademarks

            

Wholesale

 $27,192   -  $27,192 

Retail

  2,900   -   2,900 

Patents

  895  $778   117 

Total Intangibles

 $30,987  $778  $30,209 

 

(1) $45.4 million of the total resulted from our Acquisition that occurred on March 15, 2021.

 

(2) $6.3 million of the total resulted from our Acquisition that occurred on March 15, 2021.

 

(3) Resulted from our Acquisition that occurred on March 15, 2021.

 

The weighted average remaining life for our patents is 3.1 years.

 

A schedule of approximate actual and expected amortization expense related to finite-lived intangible assets is as follows:

 

  

Amortization

 

($ in thousands)

 

Expense

 

2020

 $31 

2021

  2,501 

2022

  3,149 

2023

  3,147 

2024

  3,143 

2025

  3,139 

2026

  3,136 

2027+

  28,802 

 

Indefinite lived intangible assets, such as trademarks are reviewed for impairment testing annually, more frequently if necessary. We perform such testing of indefinite-lived intangible assets in the fourth quarter of each year or as events occur or circumstances change that would more likely than not reduce the fair value of the asset below its carrying amount. Fair value of other indefinite-lived intangible assets is determined using the relief from royalty method. Definite lived intangible assets, such as patents and customer relationships are only reviewed for impairment if a triggering event has occurred to indicate that its fair value of the asset is below its carrying value.

 

In assessing whether indefinite-lived intangible assets are impaired, we must make certain estimates and assumptions regarding future cash flows, long-term growth rates of our business, operating margins, weighted average cost of capital and other factors such as: discount rates, royalty rates, cost of capital, and market multiples to determine the fair value of our assets. These estimates and assumptions require management’s judgment, and changes to these estimates and assumptions could materially affect the determination of fair value and/or impairment for each of our indefinite-lived intangible assets. Future events could cause us to conclude that indications of intangible asset impairment exist. Impairment may result from, among other things, deterioration in the performance of our business, adverse market conditions, adverse changes in applicable laws and regulations, competition, or the sale or disposition of a reporting segment. Any resulting impairment loss could have a material adverse impact on our financial condition and results of operations.

 

2021 and 2020 Impairment Testing

 

We evaluate our finite and indefinite lived intangible assets under the terms and provisions of the accounting standards for "Intangibles - Goodwill and Other" and "Property, Plant and Equipment." These pronouncements require that we compare the fair value of an intangible asset with its carrying amount. The results of our 2021 and 2020 finite and indefinite-lived intangible impairment testing indicated that all reporting unit intangible asset fair values exceed their respective carrying values.